| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |